Anti-tumor effects of dual PI3K-HDAC inhibitor CUDC-907 on activation of ROS-IRE1α-JNK-mediated cytotoxic autophagy in esophageal cancer

被引:0
|
作者
Zheng Jian
Yichao Han
Wentian Zhang
Chengqiang Li
Wei Guo
Xijia Feng
Bin Li
Hecheng Li
机构
[1] Shanghai Jiao Tong University School of Medicine,Department of Thoracic Surgery, Ruijin Hospital
[2] Tong Ji University School of Medicine,Department of Thoracic Surgery, Shanghai Pulmonary Hospital
[3] Shanghai Jiao Tong University School of Medicine,Shanghai Institute of Immunology, Department of Immunology and Microbiology
来源
Cell & Bioscience | / 12卷
关键词
PI3K-Akt; HDAC; CUDC-907; Autophagy; Esophageal cancer; CDX;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 5 条
  • [1] Anti-tumor effects of dual PI3K-HDAC inhibitor CUDC-907 on activation of ROS-IRE1α-JNK-mediated cytotoxic autophagy in esophageal cancer
    Jian, Zheng
    Han, Yichao
    Zhang, Wentian
    Li, Chengqiang
    Guo, Wei
    Feng, Xijia
    Li, Bin
    Li, Hecheng
    CELL AND BIOSCIENCE, 2022, 12 (01)
  • [2] CUDC-907, a novel dual PI3K and HDAC inhibitor, in prostate cancer: Antitumour activity and molecular mechanism of action
    Hu, Cheng
    Xia, Hongyan
    Bai, Shanshan
    Zhao, Jianlei
    Edwards, Holly
    Li, Xinyu
    Yang, Yanrong
    Lyu, Jing
    Wang, Guan
    Zhan, Yang
    Dong, Yan
    Ge, Yubin
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2020, 24 (13) : 7239 - 7253
  • [3] The dual HDAC-PI3K inhibitor CUDC-907 displays single-agent activity and synergizes with PARP inhibitor olaparib in small cell lung cancer
    Ma, Liying
    Bian, Xing
    Lin, Wenchu
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2020, 39 (01)
  • [4] The dual HDAC-PI3K inhibitor CUDC-907 displays single-agent activity and synergizes with PARP inhibitor olaparib in small cell lung cancer
    Liying Ma
    Xing Bian
    Wenchu Lin
    Journal of Experimental & Clinical Cancer Research, 39
  • [5] The PI3K/mTOR dual inhibitor NVP-BEZ235 stimulates mutant p53 degradation to exert anti-tumor effects on triple-negative breast cancer cells
    Cai, Jiajing
    Xia, Jingruo
    Zou, Jiang
    Wang, Qiang
    Ma, Qiang
    Sun, Ru
    Liao, Hebin
    Xu, Lei
    Wang, Dongsheng
    Guo, Xiaolan
    FEBS OPEN BIO, 2020, 10 (04): : 535 - 545